191 related articles for article (PubMed ID: 8712709)
1. Antitumor activity of an alkylating derivative of dipyridamole.
Andreani A; Bossa R; Fraccari A; Galatulas I; Ninci MA; Rambaldi M
Anticancer Res; 1996; 16(4A):1831-3. PubMed ID: 8712709
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxic activity of a new alkylating derivative of dipyridamole.
Andreani A; Bossa R; Galatulas I; Ninci MA; Rambaldi M
Anticancer Res; 1991; 11(1):379-80. PubMed ID: 2018374
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
Samanta S; Pain A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U
Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847
[TBL] [Abstract][Full Text] [Related]
5. Activity of 17 beta-hydroxy-3-aza-A-homo-4 alpha-androsten-4-one-p-N, N-bis(2-chloroethyl)aminophenoxyacetate (NSC-620480) in P388 leukemia. Activity of steroidal lactams in Ehrlich tumor.
Catsoulacos P; Pairas G
Methods Find Exp Clin Pharmacol; 1990 Sep; 12(7):501-5. PubMed ID: 2087151
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
[TBL] [Abstract][Full Text] [Related]
7. 9-Hydroxybenfluron: effect on energy-yielding processes in Ehrlich ascites and P388 murine leukemia cells.
Miko M; Krepelka J; Nobilis M
Anticancer Drugs; 1992 Feb; 3(1):63-8. PubMed ID: 1623218
[TBL] [Abstract][Full Text] [Related]
8. Cloturin: effect on energy-producing processes in Ehrlich ascites and P388 murine leukaemia cells.
Miko M; Krepelka J; Melka M
Cell Biochem Funct; 1992 Jun; 10(2):115-22. PubMed ID: 1628380
[TBL] [Abstract][Full Text] [Related]
9. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
Bara A; Socaciu C; Silvestru C; Haiduc I
Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
11. Potential antitumor agents XIX [1]. Synthesis and antitumor activity of tricyclic compounds related to lotifazole.
Andreani A; Rambaldi M; Locatelli A; Fraccari A; Bossa R; Galatulas I
Pharm Acta Helv; 1992; 67(8):234-6. PubMed ID: 1384067
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 2-chloroethylnitrosoureas of substituted naphthalimides as mixed-function anticancer compounds.
Samanta S; Pain A; Dutta S; Sanyal U
Acta Pol Pharm; 2001; 58(5):351-6. PubMed ID: 11876442
[TBL] [Abstract][Full Text] [Related]
13. New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies.
Orosz F; Comin B; Raïs B; Puigjaner J; Kovács J; Tárkányi G; Acs T; Keve T; Cascante M; Ovádi J
Br J Cancer; 1999 Mar; 79(9-10):1356-65. PubMed ID: 10188876
[TBL] [Abstract][Full Text] [Related]
14. Cytolytic activities of benfluron metabolites and loss of transplantability.
Miko M; Krepelka J; Melka M
Int J Tissue React; 1989; 11(3):143-51. PubMed ID: 2613458
[TBL] [Abstract][Full Text] [Related]
15. Conjugated system of homo-aza-steroidal esters in cancer chemotherapy.
Catsoulacos P; Catsoulacos D
Anticancer Res; 1994; 14(6B):2525-8. PubMed ID: 7872677
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance.
Petitclerc E; Deschesnes RG; Côté MF; Marquis C; Janvier R; Lacroix J; Miot-Noirault E; Legault J; Mounetou E; Madelmont JC; C -Gaudreault R
Cancer Res; 2004 Jul; 64(13):4654-63. PubMed ID: 15231678
[TBL] [Abstract][Full Text] [Related]
17. DNA-Directed alkylating agents. 7. Synthesis, DNA interaction, and antitumor activity of bis(hydroxymethyl)- and bis(carbamate)-substituted pyrrolizines and imidazoles.
Atwell GJ; Fan JY; Tan K; Denny WA
J Med Chem; 1998 Nov; 41(24):4744-54. PubMed ID: 9822545
[TBL] [Abstract][Full Text] [Related]
18. [Micronuclear and antitumor activities of two newly synthesized pyrimidine derivatives].
Nersesian AK; Muradian RE; Arsenian FG
Tsitologiia; 2008; 50(1):79-82. PubMed ID: 18409373
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic and antineoplastic effects by newly synthesised steroidal alkylators in lymphocytic leukaemia P388 cells in vivo.
Mourelatos C; Kareli D; Dafa E; Argyraki M; Koutsourea A; Papakonstantinou I; Fousteris M; Pairas G; Nikolaropoulos S; Lialiaris TS
Mutat Res; 2012 Jul; 746(1):1-6. PubMed ID: 22464985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
